Comparison of the Use of VAC System in Transplants of Leg Ulcers Versus Usual Dressing Method

Comparison of the Use of VAC (Vacuum Assisted Closure) System in Transplants of Leg Ulcers Versus Usual Dressing Method. A Monocentric, Prospective, Randomized, Parallel Groups Study

To evaluate the VAC (Vacuum Assisted Closure) therapy in transplants of leg ulcers versus usual dressing method. The VAC Therapy system consists of:

  • A unit delivering a precise under atmospheric pressure, controlled and regulated in the wound site,
  • Consumables necessary for the implementation of the dressing,
  • Collecting tanks exudates with gel. VAC therapy is a system using negative pressure. It is known to be efficient into care of chronic wounds and ulcerous wounds by increasing the cicatrisation.

This system is systematically used into the dermatology unit of the CHU of Saint-Etienne after transplants of leg ulcers, but no data confirms the interest of this method compared to usual dressing method. This study will provide this data.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-etienne, France, 42000
        • CHU de Saint-Etienne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patient hospitalized into the dermatology unit
  • patient with an evolutive leg ulcer since more than 1 month
  • signed informed consent

Exclusion Criteria:

  • known allergy to one of dressings used in this study
  • patient with a non-treated osteomyelitis
  • patient with tumoral tissues into the wound
  • patient with raw organ or raw blood vessels
  • patient with an anticoagulation treatment with a potentially hemorrhagic curative dose
  • patient having hemostasis problems that can lead to hemorrhagic exudates

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: V.A.C.® Therapy
In this arm, investigators will use the V.A.C.® Therapy after a transplants of leg ulcers.
Patients received V.A.C.® Therapy (KCI medical) after a transplants of leg ulcers.
Active Comparator: usual dressing method (compresses)
In this arm, investigators will use the usual dressing method after a transplants of leg ulcers.
Patients received usual dressing method (compresses) after a transplants of leg ulcers

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of healing between VAC system and compresses for all types of leg ulcers
Time Frame: 1 month after the transplant
Number of patients having a wound at least 50% of the grafted area between VAC system and compresses
1 month after the transplant

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of healing between VAC system and compresses for all types of leg ulcers
Time Frame: 3 months after the transplant
Number of patients having a wound at least 50% of the grafted area between VAC system and compresses
3 months after the transplant
Evolution of the pain by Analogic Visual Scale.
Time Frame: day 0 : just before the transplant
Pain score as measured by visual analog scale between VAC system and compresses
day 0 : just before the transplant
Evolution of the pain by Analogic Visual Scale.
Time Frame: day 1 : the day after the transplant
Pain score as measured by visual analog scale between VAC system and compresses
day 1 : the day after the transplant
Evolution of the pain by Analogic Visual Scale
Time Frame: Month 1
Pain score as measured by visual analog scale between VAC system and compresses
Month 1
Quality of life questionnaire score.
Time Frame: day 0 : just before the transplant
Quality of life questionnaire score between VAC system and compresses
day 0 : just before the transplant
Quality of life questionnaire score.
Time Frame: Day 5
Quality of life questionnaire score between VAC system and compresses
Day 5
Quality of life questionnaire score.
Time Frame: Month 1
Quality of life questionnaire score between VAC system and compresses
Month 1
Quality of life questionnaire score.
Time Frame: Month 3
Quality of life questionnaire score between VAC system and compresses
Month 3
Cost of the treatment.
Time Frame: Month 3
Cost of the treatment, between VAC system and compresses This coast includes costs of consumables, hospitalisation days and nursing costs
Month 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bruno LABEILLE, MD, CHU de Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (Actual)

October 1, 2013

Study Completion (Actual)

March 1, 2014

Study Registration Dates

First Submitted

July 21, 2015

First Submitted That Met QC Criteria

July 27, 2015

First Posted (Estimate)

July 28, 2015

Study Record Updates

Last Update Posted (Estimate)

July 28, 2015

Last Update Submitted That Met QC Criteria

July 27, 2015

Last Verified

July 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 1008042
  • 2010-A00371-38 (Other Identifier: ANSM)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Leg Ulcer

Clinical Trials on V.A.C.®

3
Subscribe